ID   CP343_HUMAN             Reviewed;         503 AA.
AC   Q9HB55; Q495Y1; Q75MK2; Q75MK3; Q9HB52; Q9HB53; Q9HB54; Q9HB57;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Cytochrome P450 3A43;
DE            EC=1.14.14.1;
GN   Name=CYP3A43;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   CHARACTERIZATION.
RX   PubMed=11160876;
RA   Domanski T.L., Finta C., Halpert J.R., Zaphiropoulos P.G.;
RT   "cDNA cloning and initial characterization of CYP3A43, a novel human
RT   cytochrome P450.";
RL   Mol. Pharmacol. 59:386-392(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11243885; DOI=10.1006/bbrc.2001.4505;
RA   Westlind A., Malmebo S., Johansson I., Otter C., Andersson T.B.,
RA   Ingelman-Sundberg M., Oscarson M.;
RT   "Cloning and tissue distribution of a novel human cytochrome P450 of
RT   the CYP3A subfamily, CYP3A43.";
RL   Biochem. Biophys. Res. Commun. 281:1349-1355(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Liver;
RX   PubMed=11266076; DOI=10.1097/00008571-200103000-00002;
RA   Gellner K., Eiselt R., Hustert E., Arnold H., Koch I., Haberl M.,
RA   Deglmann C.J., Burk O., Buntefuss D., Escher S., Bishop C.,
RA   Koebe H.-G., Brinkmann U., Klenk H.-P., Kleine K., Meyer U.A.,
RA   Wojnowski L.;
RT   "Genomic organization of the human CYP3A locus: identification of a
RT   new, inducible CYP3A gene.";
RL   Pharmacogenetics 11:111-121(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CYP3A43*2), AND VARIANT CYP3A43*3
RP   ALA-340.
RX   PubMed=14695544; DOI=10.1002/humu.9211;
RA   Cauffiez C., Lo-Guidice J.-M., Chevalier D., Allorge D., Hamdan R.,
RA   Lhermitte M., Lafitte J.-J., Colombel J.-F., Libersa C., Broly F.;
RT   "First report of a genetic polymorphism of the cytochrome P450 3A43
RT   (CYP3A43) gene: identification of a loss-of-function variant.";
RL   Hum. Mutat. 23:101-101(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TRANS-SPLICING.
RX   PubMed=11726664; DOI=10.1074/jbc.M109175200;
RA   Finta C., Zaphiropoulos P.G.;
RT   "Intergenic mRNA molecules resulting from trans-splicing.";
RL   J. Biol. Chem. 277:5882-5890(2002).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
CC   -!- FUNCTION: Exhibits low testosterone 6-beta-hydroxylase activity.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9HB55-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB55-2; Sequence=VSP_000609;
CC       Name=3;
CC         IsoId=Q9HB55-3; Sequence=VSP_000610, VSP_000611;
CC       Name=4;
CC         IsoId=Q9HB55-4; Sequence=VSP_000612, VSP_000613;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=7;
CC         IsoId=Q9HB55-6; Sequence=VSP_056736;
CC   -!- TISSUE SPECIFICITY: Highest expression level in prostate. Also
CC       expressed in liver, kidney, pancreas, fetal liver and fetal
CC       skeletal muscle. {ECO:0000269|PubMed:11160876,
CC       ECO:0000269|PubMed:11243885}.
CC   -!- INDUCTION: By rifampicin.
CC   -!- POLYMORPHISM: At protein level, three alleles are known:
CC       CYP3A43*1, CYP3A43*2 and CYP3A43*3. The sequence shown is that of
CC       CYP3A43*1, which is the most frequent allele. The allele CYP3A43*2
CC       is likely to be non-functional.
CC   -!- MISCELLANEOUS: Chimeric transcripts, characterized by CYP3A43 exon
CC       1 joined at canonical splice sites to distinct sets of CYP3A4 or
CC       CYP3A5 exons, have been detected. All are possibly produced by
CC       trans-splicing. CYP3A43-CYP3A4 chimeric transcripts exist in 3
CC       different combinations: CYP3A43 exon 1 joined in frame to CYP3A4
CC       exons 2-13, CYP3A43 exon 1 joined in frame to CYP3A4 exons 4-13
CC       and CYP3A43 exon 1 joined in frame to CYP3A4 exon 7-13. The
CC       longest chimeric isoform (CYP3A43 exon 1 joined to CYP3A4 exons 2-
CC       13) exhibits 6-beta-hydroxylase activity, while a shorter isoform
CC       (CYP3A43 exon 1 joined to CYP3A4 exons 4-13) does not. CYP3A43-
CC       CYP3A5 chimeric transcripts exist in 2 different combinations:
CC       CYP3A43 exon 1 joined in frame to CYP3A5 exon 11-13 and CYP3A43
CC       exon 1 joined in frame to CYP3A5 exon 12-13. All chimeric
CC       transcripts are expressed at very low levels in the liver
CC       (PubMed:11726664). {ECO:0000305|PubMed:11726664}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP3A43 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp3a43.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF319634; AAK00325.1; -; mRNA.
DR   EMBL; AF337813; AAK38841.1; -; mRNA.
DR   EMBL; AF280107; AAG32291.1; -; Genomic_DNA.
DR   EMBL; AF280108; AAG33009.1; -; mRNA.
DR   EMBL; AF280109; AAG33010.1; -; mRNA.
DR   EMBL; AF280110; AAG33011.1; -; mRNA.
DR   EMBL; AF280111; AAG33012.1; -; mRNA.
DR   EMBL; AY390423; AAQ92351.1; -; mRNA.
DR   EMBL; AY390424; AAQ92352.1; -; mRNA.
DR   EMBL; AY390425; AAQ92353.1; -; mRNA.
DR   EMBL; AY390426; AAQ92354.1; -; mRNA.
DR   EMBL; AC011904; AAS07394.1; -; Genomic_DNA.
DR   EMBL; AC011904; AAS07395.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76632.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76634.1; -; Genomic_DNA.
DR   EMBL; BC100981; AAI00982.1; -; mRNA.
DR   CCDS; CCDS5675.1; -. [Q9HB55-2]
DR   CCDS; CCDS5676.1; -. [Q9HB55-1]
DR   CCDS; CCDS5677.1; -. [Q9HB55-3]
DR   CCDS; CCDS64723.1; -. [Q9HB55-6]
DR   PIR; JC7627; JC7627.
DR   RefSeq; NP_001265850.1; NM_001278921.1. [Q9HB55-6]
DR   RefSeq; NP_073731.1; NM_022820.4. [Q9HB55-2]
DR   RefSeq; NP_476436.1; NM_057095.2. [Q9HB55-1]
DR   RefSeq; NP_476437.1; NM_057096.3. [Q9HB55-3]
DR   UniGene; Hs.306220; -.
DR   ProteinModelPortal; Q9HB55; -.
DR   SMR; Q9HB55; -.
DR   STRING; 9606.ENSP00000222382; -.
DR   BindingDB; Q9HB55; -.
DR   ChEMBL; CHEMBL5792; -.
DR   DrugBank; DB05239; Cobimetinib.
DR   DrugBank; DB09102; Daclatasvir.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB08930; Dolutegravir.
DR   DrugBank; DB00593; Ethosuximide.
DR   DrugBank; DB09048; Netupitant.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00780; Phenelzine.
DR   DrugBank; DB01058; Praziquantel.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB01201; Rifapentine.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB01361; Troleandomycin.
DR   DrugBank; DB00943; Zalcitabine.
DR   iPTMnet; Q9HB55; -.
DR   PhosphoSitePlus; Q9HB55; -.
DR   BioMuta; CYP3A43; -.
DR   DMDM; 20137481; -.
DR   PaxDb; Q9HB55; -.
DR   PeptideAtlas; Q9HB55; -.
DR   PRIDE; Q9HB55; -.
DR   Ensembl; ENST00000222382; ENSP00000222382; ENSG00000021461. [Q9HB55-2]
DR   Ensembl; ENST00000312017; ENSP00000312110; ENSG00000021461. [Q9HB55-3]
DR   Ensembl; ENST00000354829; ENSP00000346887; ENSG00000021461. [Q9HB55-1]
DR   Ensembl; ENST00000417625; ENSP00000416581; ENSG00000021461. [Q9HB55-6]
DR   Ensembl; ENST00000434806; ENSP00000411653; ENSG00000021461. [Q9HB55-4]
DR   GeneID; 64816; -.
DR   KEGG; hsa:64816; -.
DR   UCSC; uc003urx.3; human. [Q9HB55-1]
DR   CTD; 64816; -.
DR   DisGeNET; 64816; -.
DR   GeneCards; CYP3A43; -.
DR   H-InvDB; HIX0033547; -.
DR   HGNC; HGNC:17450; CYP3A43.
DR   HPA; HPA066463; -.
DR   HPA; HPA072245; -.
DR   MIM; 606534; gene.
DR   neXtProt; NX_Q9HB55; -.
DR   OpenTargets; ENSG00000021461; -.
DR   PharmGKB; PA427; -.
DR   eggNOG; KOG0158; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118816; -.
DR   HOGENOM; HOG000039127; -.
DR   HOVERGEN; HBG108567; -.
DR   InParanoid; Q9HB55; -.
DR   KO; K17692; -.
DR   OMA; CPESRFS; -.
DR   OrthoDB; EOG091G0JNC; -.
DR   PhylomeDB; Q9HB55; -.
DR   TreeFam; TF105087; -.
DR   Reactome; R-HSA-211958; Miscellaneous substrates.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   GeneWiki; CYP3A43; -.
DR   GenomeRNAi; 64816; -.
DR   PRO; PR:Q9HB55; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000021461; -.
DR   CleanEx; HS_CYP3A43; -.
DR   ExpressionAtlas; Q9HB55; baseline and differential.
DR   Genevisible; Q9HB55; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; ISS:UniProtKB.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR008072; Cyt_P450_E_CYP3A.
DR   InterPro; IPR002402; Cyt_P450_E_grp-II.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00464; EP450II.
DR   PRINTS; PR01689; EP450IICYP3A.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum; Heme;
KW   Iron; Membrane; Metal-binding; Microsome; Monooxygenase;
KW   Oxidoreductase; Polymorphism; Reference proteome.
FT   CHAIN         1    503       Cytochrome P450 3A43.
FT                                /FTId=PRO_0000051814.
FT   METAL       442    442       Iron (heme axial ligand). {ECO:0000250}.
FT   VAR_SEQ      56    224       GLWNFDRECNEKYGEMWGLYEGQQPMLVIMDPDMIKTVLVK
FT                                ECYSVFTNQMPLGPMGFLKSALSFAEDEEWKRIRTLLSPAF
FT                                TSVKFKEMVPIISQCGDMLVRSLRQEAENSKSINLKDFFGA
FT                                YTMDVITGTLFGVNLDSLNNPQDPFLKNMKKLLKLDFLDPF
FT                                LLLIS -> RSLNKIPSWAWWLTPVIPALWEAEAGGSPKVR
FT                                SSRPALPTWVFGILTENVMKNTEKCGA (in isoform
FT                                7). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056736.
FT   VAR_SEQ     224    250       SLFPFLTPVFEALNIGLFPKDVTHFLK -> YRVSLCCLGR
FT                                SAWCDLGSLKPPPPGFE (in isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000612.
FT   VAR_SEQ     251    503       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_000613.
FT   VAR_SEQ     417    417       E -> ES (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_000609.
FT   VAR_SEQ     419    420       FS -> SH (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_000610.
FT   VAR_SEQ     421    503       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_000611.
FT   VARIANT      25     88       YGTHSHKLFKKLGIPGPTPLPFLGTILFYLRGLWNFDRECN
FT                                EKYGEMWGLYEGQQPMLVIMDPD -> LGPIHINFLRSWEF
FT                                LGQPLCLFWELFCSTLGVFGILTENVMKNTEKCGGCMRGNS
FT                                PCWSSWIPT (in allele CYP3A43*2).
FT                                /FTId=VAR_018050.
FT   VARIANT      27     27       T -> A (in dbSNP:rs45558032).
FT                                /FTId=VAR_048449.
FT   VARIANT      89    503       Missing (in allele CYP3A43*2).
FT                                /FTId=VAR_018051.
FT   VARIANT     145    145       M -> I (in dbSNP:rs45450092).
FT                                /FTId=VAR_048450.
FT   VARIANT     275    275       M -> I (in dbSNP:rs45621431).
FT                                /FTId=VAR_048451.
FT   VARIANT     340    340       P -> A (in allele CYP3A43*3;
FT                                dbSNP:rs680055).
FT                                {ECO:0000269|PubMed:14695544}.
FT                                /FTId=VAR_018052.
SQ   SEQUENCE   503 AA;  57670 MW;  2C585B9DC573F634 CRC64;
     MDLIPNFAME TWVLVATSLV LLYIYGTHSH KLFKKLGIPG PTPLPFLGTI LFYLRGLWNF
     DRECNEKYGE MWGLYEGQQP MLVIMDPDMI KTVLVKECYS VFTNQMPLGP MGFLKSALSF
     AEDEEWKRIR TLLSPAFTSV KFKEMVPIIS QCGDMLVRSL RQEAENSKSI NLKDFFGAYT
     MDVITGTLFG VNLDSLNNPQ DPFLKNMKKL LKLDFLDPFL LLISLFPFLT PVFEALNIGL
     FPKDVTHFLK NSIERMKESR LKDKQKHRVD FFQQMIDSQN SKETKSHKAL SDLELVAQSI
     IIIFAAYDTT STTLPFIMYE LATHPDVQQK LQEEIDAVLP NKAPVTYDAL VQMEYLDMVV
     NETLRLFPVV SRVTRVCKKD IEINGVFIPK GLAVMVPIYA LHHDPKYWTE PEKFCPERFS
     KKNKDSIDLY RYIPFGAGPR NCIGMRFALT NIKLAVIRAL QNFSFKPCKE TQIPLKLDNL
     PILQPEKPIV LKVHLRDGIT SGP
//
